PFM Health Sciences LP 13D and 13G filings for Aerie Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 12:39 pm Sale | 2021-12-31 | 13G | Aerie Pharmaceuticals, Inc. AERI | PFM Health Sciences LP | 1,088,566 2.300% | -1,725,797 (-61.32%) | Filing |
| 2021-02-16 4:10 pm Purchase | 2020-12-31 | 13G | Aerie Pharmaceuticals, Inc. AERI | PFM Health Sciences LP | 2,814,363 6.000% | 382,864 (+15.75%) | Filing |
| 2020-02-14 4:05 pm Sale | 2019-12-31 | 13G | Aerie Pharmaceuticals, Inc. AERI | PFM Health Sciences LP | 2,431,499 5.200% | -244,400 (-9.13%) | Filing |